Current Cardiovascular Risk Reports

Scope & Guideline

Navigating the complexities of cardiovascular health risks.

Introduction

Delve into the academic richness of Current Cardiovascular Risk Reports with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1932-9520
PublisherSPRINGER
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2007 to 2024
AbbreviationCURR CARDIOVASC RISK / Curr. Cardiovascu. Risk Rep.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The journal 'Current Cardiovascular Risk Reports' focuses on disseminating knowledge and research findings related to cardiovascular health, risk factors, and innovative treatment strategies. It aims to integrate a multidisciplinary approach towards understanding cardiovascular diseases and promoting health equity.
  1. Cardiovascular Risk Assessment and Management:
    The journal emphasizes studies that assess various cardiovascular risk factors, including genetic, lifestyle, and social determinants, providing strategies for effective management.
  2. Technological Innovations in Cardiology:
    There is a strong focus on the application of technology, such as artificial intelligence, digital health, and telemedicine, in improving diagnosis, treatment, and patient monitoring in cardiovascular care.
  3. Health Equity and Disparities:
    A significant aspect of the journal's scope is addressing racial and ethnic disparities in cardiovascular health, emphasizing the need for equitable healthcare solutions.
  4. Women's Cardiovascular Health:
    The journal pays particular attention to cardiovascular issues specific to women, investigating risk factors, treatment responses, and outcomes.
  5. Preventive Strategies and Lifestyle Interventions:
    Research on preventive measures, including lifestyle modifications and community-based interventions, is a core area of interest, aiming to reduce cardiovascular disease incidence.
The journal has identified several trending and emerging themes that reflect current advancements in cardiovascular research and the growing importance of integrating technology in clinical practice.
  1. Artificial Intelligence in Cardiovascular Care:
    Recent publications highlight the increasing integration of AI for risk assessment, diagnosis, and treatment strategies in cardiovascular medicine, showcasing its potential to enhance clinical outcomes.
  2. Digital Health and Remote Monitoring:
    There is a growing emphasis on digital health solutions, including remote patient monitoring and telemedicine, as essential tools for managing cardiovascular diseases and improving patient engagement.
  3. Health Equity and Social Determinants of Health:
    Research focusing on health equity, particularly regarding racial and ethnic disparities in cardiovascular health, has gained momentum, highlighting the importance of addressing social determinants.
  4. Innovative Treatment Approaches:
    The journal is increasingly publishing studies on novel treatment strategies such as neuromodulation and hybrid ablation techniques, indicating a shift towards more advanced procedural approaches.
  5. Integrative Lifestyle and Behavioral Interventions:
    There is a rising trend in exploring lifestyle modifications and behavioral interventions as part of comprehensive cardiovascular risk management, emphasizing holistic patient care.

Declining or Waning

Over the years, certain themes within 'Current Cardiovascular Risk Reports' have shown a decline in prominence, reflecting changing interests and the evolving landscape of cardiovascular research.
  1. Traditional Risk Factors Focus:
    There appears to be a waning emphasis on traditional cardiovascular risk factors such as hypertension and hyperlipidemia, as newer methodologies and technologies gain traction in research.
  2. Generalized Cardiovascular Risk Management:
    The publications show a decreasing focus on generalized risk management approaches, moving towards more personalized and technology-driven strategies.
  3. Basic Cardiovascular Physiology:
    Research articles that deal with fundamental aspects of cardiovascular physiology have become less frequent, as the journal shifts towards applied and innovative research.
  4. Pharmacological Approaches without Technological Integration:
    There is a noticeable decline in studies that focus solely on pharmacological interventions without considering the integration of technological advancements or digital health solutions.

Similar Journals

Cardiovascular Therapeutics

Empowering Global Access to Cardiovascular Discoveries
Publisher: WILEY-HINDAWIISSN: 1755-5914Frequency: 1 issue/year

Cardiovascular Therapeutics is a renowned Open Access journal, published by WILEY-HINDAWI, that has been at the forefront of advancing knowledge in the field of cardiology and cardiovascular medicine since its establishment. With a strong commitment to disseminating high-quality research, the journal has successfully positioned itself within the Q2 quartile in multiple categories, including Cardiology and Cardiovascular Medicine, Medicine (miscellaneous), and Pharmacology. The journal is indexed in Scopus, achieving impressive rankings, such as #95 out of 387 in Cardiology, and #87 out of 272 in Medical Pharmacology. Situated in the United Kingdom, Cardiovascular Therapeutics embraces an Open Access model since 2019, ensuring that groundbreaking research is accessible to researchers, practitioners, and students across the globe. The journal is dedicated to publishing original research articles, reviews, and clinical studies that contribute to the understanding and treatment of cardiovascular diseases, making it an essential resource for those invested in improving patient outcomes and advancing therapeutic strategies in this vital area of medicine.

PROGRESS IN CARDIOVASCULAR DISEASES

Leading the Charge in Cardiovascular Discoveries
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0033-0620Frequency: 6 issues/year

PROGRESS IN CARDIOVASCULAR DISEASES is a leading journal in the field of cardiology and cardiovascular medicine, published by W B SAUNDERS CO-ELSEVIER INC. With an impressive impact factor that places it in the esteemed Q1 quartile of its category, this journal ranks among the top 32 out of 387 journals in its field, positioning itself in the 91st percentile. Since its inception in 1958 and continuing until 2024, it has been a prolific source of cutting-edge research, reviews, and clinical insights that contribute significantly to the understanding and treatment of cardiovascular diseases. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that all published content meets the highest standards of scientific excellence. As a key resource for researchers, practitioners, and students alike, PROGRESS IN CARDIOVASCULAR DISEASES serves as an indispensable tool for advancing knowledge and practice in cardiovascular health.

COR ET VASA

Exploring the heart of cardiology and beyond.
Publisher: CZECH SOC CARDIOLOGY & CZECH SOC CARDIOVASCULAR SURGERYISSN: 0010-8650Frequency: 6 issues/year

COR ET VASA is a prominent peer-reviewed journal in the field of cardiology and cardiovascular medicine, published by the Czech Society of Cardiology and Czech Society of Cardiovascular Surgery. Established in 1961, and continuing its legacy from 2006 to 2024, this journal serves as an essential platform for disseminating significant research findings, clinical studies, and innovative treatments in cardiovascular health. While currently positioned in the Q4 quartile, the journal aims to enhance its impact by fostering knowledge sharing among researchers, clinicians, and students alike. The journal, with its publication in Czech Republic, provides a unique perspective to the European cardiovascular community, allowing for invaluable insights and discourse. Researchers are encouraged to submit their manuscripts and contribute to the growing body of knowledge in this critical area, although it should be noted that COR ET VASA does not offer open access options at this time. As the field of cardiovascular medicine evolves, COR ET VASA remains committed to addressing the latest challenges and advancements, nurturing a rich dialogue within the community.

Indian Heart Journal

Exploring Heart Health Innovations Across Borders
Publisher: ELSEVIERISSN: 0019-4832Frequency: 6 issues/year

Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.

Journal of the American Heart Association

Transforming Cardiovascular Medicine with Open Access Insights
Publisher: WILEYISSN: Frequency: 24 issues/year

The Journal of the American Heart Association, published by WILEY, serves as a premier platform for advancing cardiovascular medicine through its commitment to open access, fostering global dissemination of cutting-edge research since 2012. It proudly holds a prestigious position within the top quartile (Q1) in the categories of Cardiology and Cardiovascular Medicine, as evidenced by its Scopus ranking of #49 out of 387 journals, placing it in the 87th percentile. With a focus on innovative studies and transformative findings, this journal is essential for cardiologists, researchers, and healthcare professionals seeking to stay at the forefront of cardiovascular knowledge. The journal aims to bridge the gap between basic science and clinical practice, presenting findings that shape the future of heart health treatment and prevention. As a resource for academic and clinical communities alike, the Journal of the American Heart Association is dedicated to enhancing the understanding and treatment of cardiovascular diseases globally.

AMERICAN JOURNAL OF CARDIOLOGY

Empowering Healthcare Professionals with Cutting-edge Insights
Publisher: EXCERPTA MEDICA INC-ELSEVIER SCIENCE INCISSN: 0002-9149Frequency: 24 issues/year

The American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.

Journal of Cardiovascular Nursing

Advancing Cardiovascular Care Through Nursing Excellence
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0889-4655Frequency: 6 issues/year

The Journal of Cardiovascular Nursing, published by Lippincott Williams & Wilkins, is a leading peer-reviewed journal in the field of cardiovascular nursing, holding a prestigious Q1 ranking in Advanced and Specialized Nursing and a Q2 ranking in Cardiology and Cardiovascular Medicine as of 2023. With an ISSN of 0889-4655 and an E-ISSN of 1550-5049, this journal has been a cornerstone for researchers and clinicians since its inception in 1986, providing vital contributions to the evolving landscape of cardiovascular care. The journal's significant impact factor underscores its role in disseminating high-quality research that informs best practices and enhances patient outcomes in cardiovascular health. While it does not currently offer open access options, the journal remains a crucial resource housed in the prestigious Scopus database, ranked 8th out of 63 in Advanced and Specialized Nursing and 187th out of 387 in Cardiology and Cardiovascular Medicine. By promoting interdisciplinary collaboration and advanced nursing techniques, the Journal of Cardiovascular Nursing is committed to improving care for patients with cardiovascular diseases.

JRSM Cardiovascular Disease

Championing open access to vital cardiovascular research.
Publisher: SAGE PUBLICATIONS LTDISSN: Frequency: 1 issue/year

JRSM Cardiovascular Disease is a leading open-access journal published by SAGE Publications Ltd, dedicated to promoting research and knowledge dissemination in the vital field of cardiovascular health. Established in 2012, the journal plays a pivotal role in advancing the understanding of cardiovascular diseases through peer-reviewed articles, clinical studies, and innovative research findings. With a focus on enhancing patient care and public health, it aims to bridge the gap between research and practice, making it an essential resource for researchers, healthcare professionals, and students alike. By facilitating open access to its content, JRSM Cardiovascular Disease ensures that significant discoveries and advancements are available to a global audience, thereby contributing to the ongoing dialogue and collaboration within the cardiovascular disease community. This journal not only highlights critical advancements but also fosters an environment for continuous education and improvement in the field.

Journal of Cardiology

Connecting researchers and clinicians in the fight against heart disease.
Publisher: ELSEVIERISSN: 0914-5087Frequency: 12 issues/year

Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.

Giornale Italiano di Cardiologia

Innovating Cardiac Care Through Rigorous Research
Publisher: PENSIERO SCIENTIFICO EDITOREISSN: 1827-6806Frequency: 12 issues/year

Giornale Italiano di Cardiologia is a premier journal in the field of cardiology, published by PENSIERO SCIENTIFICO EDITORE. Established in 1996, this journal serves as an essential platform for sharing the latest research and clinical advancements in cardiovascular medicine, particularly catering to the Italian and international medical communities. Although currently classified in the Q4 quartile for Cardiology and Cardiovascular Medicine (2023), the journal strives to enhance its impact and outreach by embracing rigorous peer-review practices and promoting high-quality submissions. With a commitment to enriching knowledge and fostering dialogue among researchers, clinicians, and students, the journal offers a collection of articles that include original research, reviews, and case studies. While currently not an Open Access publication, readers will benefit from a wealth of research insights that contribute to advancements in cardiac care and treatment strategies. As the Giornale Italiano di Cardiologia continues to evolve, it plays a vital role in bridging research and clinical practice in the cardiovascular domain.